Department of Genetic Engineering & Graduate School of Biotechnology, Kyung Hee University, Yongin 446-701, Korea.
Arch Pharm Res. 2012 Feb;35(2):201-11. doi: 10.1007/s12272-012-0201-0. Epub 2012 Feb 28.
Mesenchymal stem cells (MSCs) or MSC-like cells have been identified in a variety of different tissues that share molecular expression profiles and biological functions but also retain a unique differentiation preference depending on their tissue origins. MSCs play beneficial roles in the healing of damaged tissue by directly differentiating to many different resident cell types and/or by secreting several trophic factors that aid tissue repair. Aside from MSCs' reparative stem cell function, they drive immune responses toward immunosuppression and anti-inflammation. This novel function of MSCs opens up new avenues for clinical development of MSC immune-therapeutics to treat uncontrollable, life threatening, severe, chronic inflammation and autoimmune disease. Unexpectedly high rates of MSCs' tumor homing capacity and their tumor supporting capability have also been noted in tumor-bearing animal models. In this review, we will discuss MSCs' basic cell biology and perspectives on MSCs in terms of tissue repair, immune modulation, and tumor homing.
间充质干细胞(MSCs)或 MSC 样细胞已在多种不同的组织中被鉴定出来,它们具有相似的分子表达谱和生物学功能,但也根据其组织来源保留了独特的分化偏好。MSCs 通过直接分化为许多不同的固有细胞类型和/或分泌几种有助于组织修复的营养因子,在受损组织的修复中发挥有益作用。除了 MSCs 的修复性干细胞功能外,它们还能促进免疫反应向免疫抑制和抗炎方向发展。MSCs 的这种新功能为 MSC 免疫治疗的临床发展开辟了新途径,可用于治疗无法控制、危及生命、严重、慢性炎症和自身免疫性疾病。在荷瘤动物模型中,人们还意外地发现 MSCs 具有很高的肿瘤归巢能力和肿瘤支持能力。在这篇综述中,我们将讨论 MSCs 的基本细胞生物学以及 MSCs 在组织修复、免疫调节和肿瘤归巢方面的观点。